Starbucks China attracts bids at up to $10 billion valuation, CNBC reports

Starbucks' China business is reportedly attracting stake sale offers valuing the unit at up to $10 billion, with private equity firms Centurium Capital, Hillhouse Capital, Carlyle Group, and KKR & Co among the contenders. The formal sale process, initiated in May, involves evaluating numerous non-binding offers, potentially leading to Starbucks retaining a 30% stake in its key growth market, though a deal closure is not expected before year-end.

Analysis

Starbucks (SBUX) is reportedly advancing a formal sale process for a stake in its China operations, attracting offers that could value the unit at up to $10 billion. The process has garnered significant interest from prominent private equity firms, including Centurium Capital, Hillhouse Capital, Carlyle Group (CG), and KKR (KKR), with nearly 30 non-binding offers submitted since the process began in May. A potential deal structure involves Starbucks retaining a 30% stake, indicating a strategy to de-risk and crystallize value rather than a full exit from a key growth market. The positive sentiment score for SBUX (0.6) suggests investors view this as a value-unlocking event. However, the process remains speculative and protracted; a shortlist of bidders is expected within two months, but a final agreement is considered unlikely to be completed by year-end, highlighting a degree of execution uncertainty.

Key Decisions for Investors

• Investors should view the potential $10 billion valuation as a significant, albeit preliminary, valuation marker for Starbucks' China business and monitor for official announcements on the shortlist of bidders to gauge deal progression.
• Given the speculative nature of the report and the extended timeline, it is prudent to be cautious about fully pricing in the transaction's value and to remain aware of potential execution risks inherent in a complex, multi-party carve-out.
• A successful stake sale would materially alter Starbucks' financial profile by reducing China-specific risks and freeing up significant capital, warranting a re-evaluation of the company's future capital allocation strategy concerning buybacks, debt reduction, or other growth investments.